Showing: 1 - 1 of 1 RESULTS

Risky Breast Lumps; Bone Testing Lags in Prostate Cancer; Cancer Breathalyzer?

Benign breast lesions detected after a woman’s initial screening mammogram are more likely to become malignant. (European Breast Cancer Conference)

Younger adults who have never smoked are the group with the biggest increase in use of electronic cigarettes. (American Cancer Society, American Journal of Preventive Medicine)

The FDA issued draft guidance aimed at getting more premenopausal women enrolled in clinical trials of new drugs and biologic agents for breast cancer.

Only one-fourth of men with prostate cancer had testing for bone health and integrity after androgen deprivation therapy, which causes loss of bone mineral. (Journal of the National Comprehensive Cancer Network)

Updated results from a randomized trial supported single-agent nivolumab (Opdivo), as opposed to nivolumab-ipilimumab (Yervoy) combination therapy, as adjuvant therapy for resected melanoma, and adding nivolumab to neoadjuvant chemotherapy significantly improved pathologic complete response in resectable non-small cell lung cancer, Bristol Myers Squibb announced in separate statements.

Amgen announced that its investigational KRAS inhibitor sotorasib met the primary endpoint of objective response in a phase II clinical trial of previously treated advanced non-small cell lung cancer.

Minority patients with cancer, as compared with white patients, show increased risk of coronavirus infection, higher rates of hospitalization for COVID-19, and lower use of telehealth during the ongoing pandemic. (ASCO Quality Care Symposium)

Introduction of a pay-for-performance program in oncology practices increased prescriptions for cancer drugs supported by high-quality clinical evidence without significantly increasing the total cost of cancer care. (Penn Medicine, Journal of Clinical Oncology)

More than 100 patient organizations worldwide have formed the World Patients Alliance to increase patient involvement in shaping healthcare policy.

Surgery for benign breast disease does not interfere with breastfeeding. (American College of Surgeons)

Within a week after infusion of CAR T-cell therapy, changes in circulating DNA may identify which patients with large B-cell lymphoma will benefit from the treatment. (University of Texas MD Anderson Cancer Center)

Immune checkpoint inhibitors used to treat multiple types of cancer may aggravate systemic inflammation that drives the development of coronary atherosclerosis. (JACC: CardioOncology)

A rapid and inexpensive breath test showed promise for head and neck cancer. (Flinders University, British Journal of Cancer)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Source Article